Viewing Study NCT00403156


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2025-12-25 @ 9:11 PM
Study NCT ID: NCT00403156
Status: WITHDRAWN
Last Update Posted: 2015-12-31
First Post: 2006-11-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Sponsor: Vitreous -Retina- Macula Consultants of New York
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module